NO20004044L - Streptomyces Avertimilis gen som styrer forholdet av B2:B1 avermectiner - Google Patents

Streptomyces Avertimilis gen som styrer forholdet av B2:B1 avermectiner

Info

Publication number
NO20004044L
NO20004044L NO20004044A NO20004044A NO20004044L NO 20004044 L NO20004044 L NO 20004044L NO 20004044 A NO20004044 A NO 20004044A NO 20004044 A NO20004044 A NO 20004044A NO 20004044 L NO20004044 L NO 20004044L
Authority
NO
Norway
Prior art keywords
avertimilis
avermectins
streptomyces
gene
controls
Prior art date
Application number
NO20004044A
Other languages
English (en)
Norwegian (no)
Other versions
NO20004044D0 (no
Inventor
Kim Jonelle Stutzman-Engwall
Yoshihiro Katoh
Hamish Alastair Irvin Mcarthur
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20004044D0 publication Critical patent/NO20004044D0/no
Publication of NO20004044L publication Critical patent/NO20004044L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20004044A 1998-02-13 2000-08-11 Streptomyces Avertimilis gen som styrer forholdet av B2:B1 avermectiner NO20004044L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7463698P 1998-02-13 1998-02-13
PCT/IB1999/000130 WO1999041389A1 (en) 1998-02-13 1999-01-25 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins

Publications (2)

Publication Number Publication Date
NO20004044D0 NO20004044D0 (no) 2000-08-11
NO20004044L true NO20004044L (no) 2000-10-11

Family

ID=22120706

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004044A NO20004044L (no) 1998-02-13 2000-08-11 Streptomyces Avertimilis gen som styrer forholdet av B2:B1 avermectiner

Country Status (32)

Country Link
EP (1) EP1053335A1 (is)
JP (2) JP2002503473A (is)
KR (3) KR20040099389A (is)
CN (2) CN1297485A (is)
AP (1) AP9901463A0 (is)
AR (1) AR018085A1 (is)
AU (1) AU752343C (is)
BG (1) BG64911B1 (is)
BR (1) BR9907893A (is)
CA (2) CA2320031A1 (is)
CO (1) CO5070698A1 (is)
DZ (1) DZ2720A1 (is)
EA (1) EA003905B1 (is)
GT (1) GT199900014A (is)
HN (1) HN1999000008A (is)
HR (1) HRP20000539A2 (is)
HU (1) HUP0100784A3 (is)
IL (2) IL137610A0 (is)
IS (1) IS5567A (is)
MA (1) MA24760A1 (is)
NO (1) NO20004044L (is)
NZ (2) NZ518657A (is)
OA (1) OA11449A (is)
PA (1) PA8467601A1 (is)
PE (1) PE20000352A1 (is)
PL (1) PL194270B1 (is)
SK (1) SK11722000A3 (is)
TN (1) TNSN99017A1 (is)
TW (1) TW585910B (is)
WO (1) WO1999041389A1 (is)
YU (1) YU50900A (is)
ZA (1) ZA991138B (is)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248579B1 (en) * 1998-02-13 2001-06-19 Pfizer Inc Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins
KR20040099389A (ko) * 1998-02-13 2004-11-26 화이자 프로덕츠 인코포레이티드 스트렙토마이세스 하이그로스코피쿠스 유전자
DE60031126T2 (de) 1999-08-12 2007-02-08 Pfizer Products Inc., Groton Streptomyces avermitilis gen zum regulieren des verhältnisses der b2:b1 avermectinen
US7630836B2 (en) 2001-05-30 2009-12-08 The Kitasato Institute Polynucleotides
EP1476539B1 (en) 2002-02-12 2009-03-25 Pfizer Products Inc. Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
CN107338210B (zh) * 2017-09-05 2021-08-17 天津科技大学 一种阿维链霉菌合成培养基及其发酵液的制备方法
CN111269296B (zh) * 2020-03-06 2021-11-05 山东大学 一种nLsA蛋白及其结构基因和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE434277B (sv) * 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4429042A (en) * 1978-09-08 1984-01-31 Merck & Co., Inc. Strain of Streptomyces for producing antiparasitic compounds
IN167980B (is) * 1987-01-23 1991-01-19 Pfizer
DE3881147T2 (de) * 1987-10-23 1993-09-02 Pfizer Verfahren zur herstellung von aglykonen von avermectin und sie enthaltende kulturen.
JPH0747171B2 (ja) * 1988-09-20 1995-05-24 株式会社東芝 圧延機の設定方法および装置
US5252474A (en) * 1989-03-31 1993-10-12 Merck & Co., Inc. Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use
DE69023036T2 (de) * 1989-03-31 1996-06-13 Merck & Co Inc Klonierung von Streptomyces avermitilis Genen zur Biosynthese von Avermectin und Verfahren zu ihrer Verwendung.
JP2888586B2 (ja) * 1990-03-05 1999-05-10 社団法人北里研究所 エバーメクチンの特定成分を選択生産するための微生物およびその選択的製造法
FI942725A (fi) * 1993-12-16 1995-06-17 Pfizer Haaraketjuista alfaketohappodenydrogenaasikompleksia koodaavia geenejä Streptomyces avermitiliksesta
KR20040099389A (ko) * 1998-02-13 2004-11-26 화이자 프로덕츠 인코포레이티드 스트렙토마이세스 하이그로스코피쿠스 유전자

Also Published As

Publication number Publication date
KR100499214B1 (ko) 2005-07-07
AU752343C (en) 2005-11-03
BG104759A (en) 2001-04-30
KR20010052166A (ko) 2001-06-25
SK11722000A3 (sk) 2001-04-09
PL194270B1 (pl) 2007-05-31
CA2521289A1 (en) 1999-08-19
CN1521180A (zh) 2004-08-18
IL137610A0 (en) 2001-07-24
JP2002503473A (ja) 2002-02-05
IL183596A0 (is) 2007-09-20
NO20004044D0 (no) 2000-08-11
HUP0100784A3 (en) 2004-10-28
IS5567A (is) 2000-07-20
DZ2720A1 (fr) 2003-09-01
AU752343B2 (en) 2002-09-19
BR9907893A (pt) 2000-11-14
ZA991138B (en) 2000-08-14
PE20000352A1 (es) 2000-05-16
NZ518657A (en) 2003-10-31
EA200000758A1 (ru) 2001-04-23
MA24760A1 (fr) 1999-10-01
KR20040053390A (ko) 2004-06-23
AP9901463A0 (en) 1999-03-31
JP4011036B2 (ja) 2007-11-21
PA8467601A1 (es) 2000-09-29
YU50900A (sh) 2004-03-12
AR018085A1 (es) 2001-10-31
WO1999041389A1 (en) 1999-08-19
KR20040099389A (ko) 2004-11-26
TNSN99017A1 (fr) 2005-11-10
JP2004283174A (ja) 2004-10-14
AU1887899A (en) 1999-08-30
EA003905B1 (ru) 2003-10-30
HRP20000539A2 (en) 2001-04-30
GT199900014A (es) 2000-07-25
HUP0100784A2 (hu) 2001-06-28
CA2320031A1 (en) 1999-08-19
HN1999000008A (es) 1999-10-29
BG64911B1 (bg) 2006-08-31
EP1053335A1 (en) 2000-11-22
OA11449A (en) 2003-12-03
PL342468A1 (en) 2001-06-04
CN1297485A (zh) 2001-05-30
NZ505676A (en) 2003-02-28
CO5070698A1 (es) 2001-08-28
TW585910B (en) 2004-05-01

Similar Documents

Publication Publication Date Title
DE69941559D1 (de) Enzymgemisch
AU6054199A (en) Computer having packet-based interconnect channel
AU8002698A (en) Building component structure, or building components
AU1543800A (en) Dynamic collimators
NO20012424L (no) Stabilisering av makrolider
NO20042112L (no) Anvendelse av glycosider av mono- og diacylglycerol som anti-inflammatoriske midler.
IS5872A (is) Gen úr 1-desoxý-D-xýlulósa lífefnaferlinu
ZA9811833B (en) Pharmaceutical compositions of uridine triphosphate.
NO20004044L (no) Streptomyces Avertimilis gen som styrer forholdet av B2:B1 avermectiner
AU5762099A (en) The preparation of (n)-substituted-hydroxycycloalkylamine derivatives
NO20020665D0 (no) Streptomyces Avermitilis gen som bestemmer forholdet til B2:B1 avermectiner
NO20020664L (no) Streptomyces Avermitilis gen som bestemmer forholdet B2:B1 avermectiner
HK1074644A1 (en) Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
FI971590A0 (fi) Anordning foer foerdelning av inluft till rumsutrymmen som skall luftkonditioneras
AU4278499A (en) Fire-resisting wall
DE59906737D1 (de) Zündbrenner
AU2930601A (en) Methods of increasing the glucose responsiveness of pancreatic beta-cells
AU1455000A (en) Stabilization of the reagent dimethyl titanocene
DK1200605T3 (da) Streptomyces avermitilis gen, der dirigerer forholdet imellem B2:B1 avermectiner
AU8528398A (en) The structure of the shoe
FI980755A0 (fi) Foerfarande foer montering/faestande av vaermeisoleringsskivor som vaermeisolering i en byggnad
NO20011268D0 (no) Forbindelse til behandling av depresjon
FI974283A0 (fi) Foerfarande foer anbringande pao vaegytan av medel som foerhindrar koerspaorsbildning
AU8622398A (en) The structure of the clogs
ES1041192Y (es) Ladrillo para la construccion de fachadas.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application